DSGN stock

Design Therapeutics Inc (DSGN) financials · $214.0M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Design Therapeutics Inc (DSGN) $214.0M cap.

Cached annual income statement
LineFY2025FY2024
RevenueN/AN/A
Operating Income-$79.5M-$62.4M
Net Income-$69.8M-$49.6M
EPS (Diluted)-$1.22-$0.88
Cached annual balance sheet
LineFY2025FY2024
Total Assets$226.2M$252.1M
Current Assets$223.8M$248.0M
Cash & Equivalents$16.9M$22.6M
PP&E$981.0K$1.41M
Total Liabilities$13.7M$10.00M
Current Liabilities$13.1M$8.46M
Shareholders' Equity$212.5M$242.1M
Retained Earnings-$297.0M-$227.2M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$54.4M-$43.1M
CapEx$193.0K$340.0K
Investing Cash Flow$22.9M$44.0M
Financing Cash Flow$25.7M$513.0K
Net Change in Cash-$5.71M$1.36M
Free Cash Flow-$54.6M-$43.4M
These statements as JSON? API free 100/day

FAQ

What is DSGN P/E and revenue?

Design Therapeutics Inc (DSGN) $214.0M cap.

What is DSGN revenue?

DSGN income-statement cache has no revenue figure yet.

Is DSGN profitable?

Design Therapeutics Inc last cached net income is -$69.8M (FY2025).

What are DSGN total assets?

Design Therapeutics Inc last cached total assets are $226.2M (FY2025).

What is DSGN free cash flow?

Design Therapeutics Inc last cached free cash flow is -$54.6M (FY2025).

Not investment advice. Cached statements, not a live tape.